SILK News and Press, Silk Road Medical Inc. From 03/31/23

2023-03-31 13:01:59 ET B. Riley Securities launched its coverage of MedTech firm Silk Road Medical ( NASDAQ: SILK ) with a Buy rating on Friday, noting the stock's undervaluation despite its potential in the market for carotid artery disease (CAD). The analyst Neil Chatter...

2023-03-05 10:45:38 ET Summary “A 3-5 month prospect from here of SILK share prices could reasonably range from a $47.07 low to a $61.27 high from its $47.29 present price, a gain of +29.6%." The result of 54 positions like today’s in the past 4 years of 874 market d...

Silk Road Medical, Inc (SILK) Q4 2022 Results Conference Call February 28, 2023 04:30 PM ET Company Participants Marissa Bych - Investor Relations Erica Rogers - Chief Executive Officer Lucas Buchanan - Chief Financial Officer and Chief Operating Officer Conferen...

Silk Road Medical press release ( NASDAQ: SILK ): Q4 GAAP EPS of -$0.34 beats by $0.04 . Revenue of $40.07M (+41.6% Y/Y) beats by $2.72M . For further details see: Silk Road Medical GAAP EPS of -$0.34 beats by $0.04, revenue of $40.07M beats by $2.72M

SUNNYVALE, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2022. “Our fourth quarter c...

SUNNYVALE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2022 after market close on Tuesday, Febru...

Summary Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. When the end to restrictive policy is in sight, then the sector is likely to witness a group rotation to more growth-oriented stocks. Groups like medical d...

SUNNYVALE, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. Silk Roa...

Silk Road Medical, Inc. (SILK) Q3 2022 Earnings Conference Call November 8, 2022 04:30 PM ET Company Participants Marissa Bych - IR Erica Rogers - President & CEO Lucas Buchanan - CFO & Chief Operating Officer Conference Call Participants Rick...

Silk Road Medical press release ( NASDAQ: SILK ): Q3 GAAP EPS of -$0.29 beats by $0.14 . Revenue of $37.4M (+51.4% Y/Y) beats by $3.76M . Cash, cash equivalents and short-term investments were $105.1 million as of September 30, 2022. Gross profit for the th...